Netflix, Inc. (NASDAQ: NFLX) Stock Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/30/2024 | — | Seaport Global | Downgrades | Buy → Neutral | |
| 01/26/2024 | -2.66% | Citigroup | $500 → $555 | Maintains | Neutral |
| 01/25/2024 | -0.91% | Goldman Sachs | $500 → $565 | Maintains | Neutral |
| 01/25/2024 | 5.23% | DZ Bank | → $600 | Upgrades | Hold → Buy |
| 01/24/2024 | -16.69% | Barclays | $375 → $475 | Maintains | Equal-Weight |
| 01/24/2024 | 5.23% | Morgan Stanley | $550 → $600 | Maintains | Overweight |
| 01/24/2024 | -0.91% | Goldman Sachs | $500 → $565 | Maintains | Neutral |
| 01/24/2024 | 11.89% | BMO Capital | $566 → $638 | Maintains | Outperform |
| 01/24/2024 | 14% | Wells Fargo | $460 → $650 | Maintains | Overweight |
| 01/24/2024 | -0.03% | UBS | $560 → $570 | Maintains | Buy |
| 01/24/2024 | -3.54% | Piper Sandler | $475 → $550 | Maintains | Neutral |
| 01/24/2024 | 4.35% | Macquarie | $410 → $595 | Upgrades | Neutral → Outperform |
| 01/24/2024 | 7.86% | Wedbush | $525 → $615 | Maintains | Outperform |
| 01/24/2024 | -7.92% | Deutsche Bank | $460 → $525 | Downgrades | Buy → Hold |
| 01/24/2024 | 1.72% | Keybanc | $545 → $580 | Maintains | Overweight |
| 01/19/2024 | -25.46% | Benchmark | $350 → $425 | Maintains | Sell |
| 01/18/2024 | -5.12% | Seaport Global | $482 → $541 | Maintains | Buy |
| 01/18/2024 | -16.69% | Piper Sandler | $400 → $475 | Maintains | Neutral |
| 01/18/2024 | -1.79% | UBS | $500 → $560 | Maintains | Buy |
| 01/17/2024 | 2.6% | B of A Securities | $525 → $585 | Maintains | Buy |
| 01/17/2024 | -4.42% | Keybanc | $525 → $545 | Maintains | Overweight |
| 01/12/2024 | 5.23% | Oppenheimer | $475 → $600 | Maintains | Outperform |
| 01/09/2024 | -12.31% | Goldman Sachs | $400 → $500 | Maintains | Neutral |
| 01/09/2024 | -0.73% | BMO Capital | → $566 | Initiates Coverage On | → Outperform |
| 01/09/2024 | -12.31% | Citigroup | → $500 | Downgrades | Buy → Neutral |
| 12/28/2023 | -7.92% | Keybanc | $510 → $525 | Maintains | Overweight |
| 12/22/2023 | -13.19% | DZ Bank | → $495 | Downgrades | Buy → Hold |
| 12/21/2023 | -7.92% | Wedbush | → $525 | Reiterates | Outperform → Outperform |
| 12/18/2023 | -3.54% | Morgan Stanley | $475 → $550 | Maintains | Overweight |
| 10/19/2023 | -16.69% | Morgan Stanley | $430 → $475 | Upgrades | Equal-Weight → Overweight |
| 10/19/2023 | -15.82% | JP Morgan | $455 → $480 | Maintains | Overweight |
| 10/19/2023 | -19.32% | Guggenheim | → $460 | Reiterates | Buy → Buy |
| 10/19/2023 | -7.92% | Wedbush | → $525 | Reiterates | Outperform → Outperform |
| 10/19/2023 | -18.45% | Truist Securities | $430 → $465 | Upgrades | Hold → Buy |
| 10/19/2023 | -16.69% | Oppenheimer | $470 → $475 | Maintains | Outperform |
| 10/19/2023 | -29.15% | Rosenblatt | $400 → $404 | Maintains | Neutral |
| 10/19/2023 | -10.55% | Keybanc | → $510 | Upgrades | Sector Weight → Overweight |
| 10/17/2023 | -24.59% | Truist Securities | $485 → $430 | Maintains | Hold |
| 10/16/2023 | -43% | Benchmark | → $325 | Reiterates | Sell → Sell |
| 10/13/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 10/11/2023 | -29.85% | Piper Sandler | $440 → $400 | Maintains | Neutral |
| 10/11/2023 | -24.59% | Morgan Stanley | $450 → $430 | Maintains | Equal-Weight |
| 10/09/2023 | -31.6% | Goldman Sachs | $400 → $390 | Maintains | Neutral |
| 10/09/2023 | — | Needham | Reiterates | → Hold | |
| 10/06/2023 | -15.47% | Seaport Global | → $482 | Initiates Coverage On | → Buy |
| 10/06/2023 | -7.92% | Wedbush | → $525 | Reiterates | Outperform → Outperform |
| 10/06/2023 | -34.23% | Bernstein | → $375 | Initiates Coverage On | → Market Perform |
| 10/04/2023 | -43% | Benchmark | → $325 | Reiterates | Sell → Sell |
| 09/28/2023 | -20.2% | JP Morgan | $505 → $455 | Maintains | Overweight |
| 09/22/2023 | -17.57% | Oppenheimer | $515 → $470 | Maintains | Outperform |
| 09/18/2023 | -12.31% | Evercore ISI Group | $550 → $500 | Maintains | Outperform |
| 09/15/2023 | -14.94% | Truist Securities | → $485 | Reiterates | Hold → Hold |
| 09/14/2023 | -48.61% | Benchmark | → $293 | Reiterates | Sell → Sell |
| 08/30/2023 | -14.94% | Truist Securities | $339 → $485 | Maintains | Hold |
| 08/25/2023 | -12.31% | Loop Capital | $425 → $500 | Upgrades | Hold → Buy |
| 08/23/2023 | -9.68% | Oppenheimer | → $515 | Reiterates | Outperform → Outperform |
| 07/26/2023 | — | Needham | Reiterates | → Hold | |
| 07/24/2023 | -12.31% | Baird | $340 → $500 | Upgrades | Neutral → Outperform |
| 07/20/2023 | -12.31% | Wells Fargo | $500 → $500 | Reiterates | Overweight → Overweight |
| 07/20/2023 | -9.68% | Oppenheimer | $500 → $515 | Maintains | Outperform |
| 07/20/2023 | -3.54% | Evercore ISI Group | $400 → $550 | Maintains | Outperform |
| 07/20/2023 | -11.43% | JP Morgan | $495 → $505 | Maintains | Overweight |
| 07/20/2023 | — | Keybanc | Maintains | Sector Weight | |
| 07/20/2023 | -7.92% | Canaccord Genuity | $470 → $525 | Maintains | Buy |
| 07/20/2023 | -21.08% | Morgan Stanley | $450 → $450 | Reiterates | Equal-Weight → Equal-Weight |
| 07/20/2023 | -12.31% | Guggenheim | → $500 | Reiterates | Buy → Buy |
| 07/20/2023 | -7.92% | Wedbush | $475 → $525 | Maintains | Outperform |
| 07/20/2023 | -35.11% | Credit Suisse | → $370 | Reiterates | Neutral → Neutral |
| 07/20/2023 | -29.85% | Rosenblatt | $358 → $400 | Maintains | Neutral |
| 07/20/2023 | -7.92% | B of A Securities | $490 → $525 | Maintains | Buy |
| 07/20/2023 | 5.23% | Pivotal Research | $535 → $600 | Maintains | Buy |
| 07/20/2023 | -12.31% | Wolfe Research | $485 → $500 | Maintains | Outperform |
| 07/20/2023 | -22.83% | Piper Sandler | $350 → $440 | Maintains | Neutral |
| 07/20/2023 | -14.94% | Deutsche Bank | $475 → $485 | Maintains | Buy |
| 07/14/2023 | -16.69% | Wedbush | → $475 | Reiterates | Outperform → Outperform |
| 07/13/2023 | -13.19% | JP Morgan | $470 → $495 | Maintains | Overweight |
| 07/12/2023 | -7.92% | UBS | $390 → $525 | Maintains | Buy |
| 07/11/2023 | -29.85% | Evercore ISI Group | $400 → $400 | Reiterates | Outperform → Outperform |
| 07/10/2023 | -21.08% | Morgan Stanley | $350 → $450 | Maintains | Equal-Weight |
| 07/06/2023 | -29.85% | Goldman Sachs | $230 → $400 | Maintains | Neutral |
| 07/05/2023 | -29.85% | Goldman Sachs | $230 → $400 | Upgrades | Sell → Neutral |
| 06/28/2023 | -12.31% | Oppenheimer | $450 → $500 | Maintains | Outperform |
| 06/21/2023 | -56.15% | Benchmark | → $250 | Reiterates | Sell → Sell |
| 06/14/2023 | -14.94% | Wolfe Research | $388 → $485 | Reiterates | → Outperform |
| 06/14/2023 | -34.23% | Barclays | $250 → $375 | Maintains | Equal-Weight |
| 06/13/2023 | -14.06% | B of A Securities | $410 → $490 | Maintains | Buy |
| 06/13/2023 | -12.31% | Guggenheim | $375 → $500 | Maintains | Buy |
| 06/07/2023 | -12.31% | Wells Fargo | $400 → $500 | Maintains | Overweight |
| 06/07/2023 | -17.57% | JP Morgan | $380 → $470 | Maintains | Overweight |
| 05/24/2023 | -21.08% | Oppenheimer | $415 → $450 | Maintains | Outperform |
| 05/19/2023 | -28.09% | Wedbush | → $410 | Reiterates | Outperform → Outperform |
| 04/19/2023 | -28.97% | Jefferies | $415 → $405 | Maintains | Buy |
| 04/19/2023 | -25.46% | Pivotal Research | $400 → $425 | Maintains | Buy |
| 04/19/2023 | -56.15% | Benchmark | → $250 | Reiterates | → Sell |
| 04/19/2023 | -37.39% | Rosenblatt | $343 → $357 | Maintains | Neutral |
| 04/19/2023 | -38.62% | Piper Sandler | $325 → $350 | Maintains | Neutral |
| 04/19/2023 | -33.35% | JP Morgan | $390 → $380 | Maintains | Overweight |
| 04/19/2023 | -28.09% | Deutsche Bank | $400 → $410 | Maintains | Buy |
| 04/19/2023 | -31.6% | UBS | $350 → $390 | Upgrades | Neutral → Buy |
| 04/18/2023 | -39.84% | Rosenblatt | → $343 | Reiterates | → Neutral |
| 04/17/2023 | -41.6% | New Street Research | $320 → $333 | Maintains | Neutral |
| 03/21/2023 | -56.15% | Benchmark | → $250 | Reiterates | → Sell |
| 03/16/2023 | -29.85% | Citigroup | $395 → $400 | Maintains | Buy |
| 02/06/2023 | -25.46% | Jefferies | $400 → $425 | Maintains | Buy |
| 01/23/2023 | -31.6% | Argus Research | $340 → $390 | Maintains | Buy |
| 01/20/2023 | -29.85% | Canaccord Genuity | $365 → $400 | Maintains | Buy |
| 01/20/2023 | -34.23% | Guggenheim | $305 → $375 | Maintains | Buy |
| 01/20/2023 | -56.15% | Benchmark | $225 → $250 | Maintains | Sell |
| 01/20/2023 | -27.22% | Oppenheimer | $400 → $415 | Maintains | Outperform |
| 01/20/2023 | -39.84% | Rosenblatt | $226 → $343 | Maintains | Neutral |
| 01/20/2023 | -56.15% | Barclays | $235 → $250 | Maintains | Equal-Weight |
| 01/20/2023 | -43% | Baird | $275 → $325 | Maintains | Neutral |
| 01/20/2023 | -48.96% | Credit Suisse | $271 → $291 | Maintains | Neutral |
| 01/20/2023 | -31.6% | JP Morgan | $330 → $390 | Maintains | Overweight |
| 01/20/2023 | -26.87% | Wolfe Research | $366 → $417 | Maintains | Outperform |
| 01/20/2023 | -29.85% | Evercore ISI Group | $340 → $400 | Maintains | Outperform |
| 01/20/2023 | -29.85% | Jefferies | $385 → $400 | Maintains | Buy |
| 01/20/2023 | -43% | Piper Sandler | $270 → $325 | Maintains | Neutral |
| 01/20/2023 | -38.62% | Morgan Stanley | $300 → $350 | Maintains | Equal-Weight |
| 01/19/2023 | -47.39% | Morgan Stanley | $275 → $300 | Maintains | Equal-Weight |
| 01/17/2023 | -40.55% | Truist Securities | $210 → $339 | Maintains | Hold |
| 01/17/2023 | -29.85% | Wedbush | $325 → $400 | Maintains | Outperform |
| 01/17/2023 | -38.62% | UBS | $250 → $350 | Maintains | Neutral |
| 01/13/2023 | -29.85% | Oppenheimer | $365 → $400 | Maintains | Outperform |
| 01/12/2023 | -32.48% | Jefferies | $310 → $385 | Upgrades | Hold → Buy |
| 01/10/2023 | -60.54% | Goldman Sachs | $200 → $225 | Maintains | Sell |
| 01/04/2023 | -46.68% | New Street Research | → $304 | Initiates Coverage On | → Neutral |
| 12/29/2022 | -45.63% | CFRA | → $310 | Upgrades | Sell → Buy |
| 12/19/2022 | -51.77% | Morgan Stanley | $250 → $275 | Maintains | Equal-Weight |
| 12/09/2022 | -29.85% | Wells Fargo | $300 → $400 | Upgrades | Equal-Weight → Overweight |
| 11/30/2022 | -62.29% | Societe Generale | $170 → $215 | Maintains | Sell |
| 11/15/2022 | -35.11% | B of A Securities | → $370 | Reinstates | → Buy |
| 10/25/2022 | -42.12% | Daiwa Capital | $226 → $330 | Upgrades | Neutral → Outperform |
| 10/19/2022 | -56.15% | Morgan Stanley | $230 → $250 | Maintains | Equal-Weight |
| 10/19/2022 | -50.02% | Macquarie | $230 → $285 | Maintains | Neutral |
| 10/19/2022 | -60.36% | Rosenblatt | $201 → $226 | Maintains | Neutral |
| 10/19/2022 | -35.99% | Oppenheimer | $325 → $365 | Maintains | Outperform |
| 10/19/2022 | -40.37% | Cowen & Co. | $325 → $340 | Maintains | Outperform |
| 10/19/2022 | -43% | Wedbush | $280 → $325 | Maintains | Outperform |
| 10/19/2022 | -71.59% | Benchmark | $157 → $162 | Maintains | Sell |
| 10/19/2022 | -38.62% | Deutsche Bank | → $350 | Upgrades | Hold → Buy |
| 10/19/2022 | -58.78% | Barclays | $170 → $235 | Maintains | Equal-Weight |
| 10/19/2022 | -52.47% | Credit Suisse | $263 → $271 | Maintains | Neutral |
| 10/19/2022 | -64.92% | Pivotal Research | $175 → $200 | Maintains | Sell |
| 10/19/2022 | -52.65% | Piper Sandler | $215 → $270 | Maintains | Neutral |
| 10/19/2022 | -42.12% | JP Morgan | $240 → $330 | Upgrades | Neutral → Overweight |
| 10/14/2022 | -56.15% | UBS | $198 → $250 | Maintains | Neutral |
| 09/28/2022 | -50.37% | Atlantic Equities | $211 → $283 | Upgrades | Neutral → Overweight |
| 09/19/2022 | -43% | Oppenheimer | → $325 | Upgrades | Perform → Outperform |
| 09/16/2022 | -46.51% | Citigroup | $275 → $305 | Maintains | Buy |
| 09/15/2022 | -47.39% | Evercore ISI Group | $245 → $300 | Upgrades | In-Line → Outperform |
| 09/07/2022 | -59.66% | Macquarie | $170 → $230 | Upgrades | Underperform → Neutral |
| 09/07/2022 | -59.66% | Jefferies | $243 → $230 | Maintains | Hold |
| 08/22/2022 | -58.26% | CFRA | $245 → $238 | Downgrades | Hold → Sell |
| 07/20/2022 | -59.66% | Morgan Stanley | $220 → $230 | Maintains | Equal-Weight |
| 07/20/2022 | -64.75% | Rosenblatt | $196 → $201 | Maintains | Neutral |
| 07/20/2022 | -70.18% | Macquarie | $150 → $170 | Maintains | Underperform |
| 07/20/2022 | -57.91% | Baird | $260 → $240 | Maintains | Neutral |
| 07/20/2022 | -57.91% | JP Morgan | $230 → $240 | Maintains | Neutral |
| 07/20/2022 | -52.65% | Deutsche Bank | $300 → $270 | Maintains | Hold |
| 07/20/2022 | -53.87% | Credit Suisse | $350 → $263 | Maintains | Neutral |
| 07/20/2022 | -69.31% | Pivotal Research | $235 → $175 | Maintains | Sell |
| 07/20/2022 | -62.29% | Piper Sandler | $210 → $215 | Maintains | Neutral |
| 07/20/2022 | -56.15% | Stifel | $240 → $250 | Upgrades | Hold → Buy |
| 07/18/2022 | -65.62% | Rosenblatt | $245 → $196 | Maintains | Neutral |
| 07/15/2022 | -65.27% | UBS | $355 → $198 | Maintains | Neutral |
| 07/14/2022 | -35.99% | BMO Capital | $405 → $365 | Maintains | Outperform |
| 07/12/2022 | -61.42% | Morgan Stanley | $300 → $220 | Maintains | Equal-Weight |
| 07/07/2022 | -57.03% | Evercore ISI Group | $300 → $245 | Maintains | In-Line |
| 07/07/2022 | -51.77% | Citigroup | $295 → $275 | Maintains | Buy |
| 07/06/2022 | -70.18% | Barclays | $275 → $170 | Maintains | Equal-Weight |
| 07/05/2022 | -63.17% | Piper Sandler | $293 → $210 | Maintains | Neutral |
| 07/01/2022 | -63.17% | Truist Securities | $300 → $210 | Maintains | Hold |
| 06/29/2022 | -59.66% | JP Morgan | $300 → $230 | Maintains | Neutral |
| 06/21/2022 | -57.91% | Stifel | $300 → $240 | Maintains | Hold |
| 06/14/2022 | -72.46% | Benchmark | → $157 | Downgrades | Hold → Sell |
| 06/14/2022 | -70.18% | Societe Generale | $330 → $170 | Maintains | Sell |
| 06/10/2022 | -67.38% | Goldman Sachs | $265 → $186 | Downgrades | Neutral → Sell |
| 06/02/2022 | -54.22% | Wolfe Research | $497 → $261 | Maintains | Outperform |
| 06/02/2022 | -53.52% | Guggenheim | $350 → $265 | Maintains | Buy |
| 05/16/2022 | — | Wedbush | Upgrades | Neutral → Outperform | |
| 04/21/2022 | -50.89% | DZ Bank | → $280 | Downgrades | Buy → Hold |
| 04/21/2022 | -47.39% | Morgan Stanley | $425 → $300 | Maintains | Equal-Weight |
| 04/21/2022 | — | Loop Capital | Downgrades | Buy → Hold | |
| 04/21/2022 | -48.26% | Citigroup | $450 → $295 | Maintains | Buy |
| 04/21/2022 | — | Edward Jones | Downgrades | Buy → Hold | |
| 04/20/2022 | -38.62% | KGI Securities | → $350 | Downgrades | Outperform → Neutral |
| 04/20/2022 | -57.03% | Rosenblatt | $354 → $245 | Maintains | Neutral |
| 04/20/2022 | -50.89% | Wedbush | $342 → $280 | Maintains | Neutral |
| 04/20/2022 | -47.39% | Evercore ISI Group | $525 → $300 | Maintains | In-Line |
| 04/20/2022 | -43% | Cowen & Co. | $590 → $325 | Maintains | Outperform |
| 04/20/2022 | -38.62% | Guggenheim | $555 → $350 | Maintains | Buy |
| 04/20/2022 | -53.52% | Goldman Sachs | $420 → $265 | Maintains | Neutral |
| 04/20/2022 | -29.85% | Canaccord Genuity | $600 → $400 | Maintains | Buy |
| 04/20/2022 | -47.39% | Deutsche Bank | $465 → $300 | Maintains | Hold |
| 04/20/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 04/20/2022 | -28.97% | BMO Capital | $640 → $405 | Maintains | Outperform |
| 04/20/2022 | — | Needham | Upgrades | Underperform → Hold | |
| 04/20/2022 | -38.62% | Credit Suisse | $450 → $350 | Maintains | Neutral |
| 04/20/2022 | -47.39% | B of A Securities | $605 → $300 | Downgrades | Buy → Underperform |
| 04/20/2022 | -51.77% | Barclays | $380 → $275 | Maintains | Equal-Weight |
| 04/20/2022 | -37.74% | UBS | → $355 | Downgrades | Buy → Neutral |
| 04/20/2022 | -47.39% | Stifel | → $300 | Downgrades | Buy → Hold |
| 04/20/2022 | -58.78% | Pivotal Research | $550 → $235 | Downgrades | Buy → Sell |
| 04/20/2022 | -48.61% | Piper Sandler | $562 → $293 | Downgrades | Overweight → Neutral |
| 04/20/2022 | -50.89% | Atlantic Equities | → $280 | Downgrades | Overweight → Neutral |
| 04/20/2022 | -47.39% | JP Morgan | → $300 | Downgrades | Overweight → Neutral |
| 04/19/2022 | -37.91% | Rosenblatt | → $354 | Initiates Coverage On | → Neutral |
| 04/14/2022 | -25.46% | Morgan Stanley | $450 → $425 | Maintains | Equal-Weight |
| 04/13/2022 | 12.25% | BMO Capital | $650 → $640 | Maintains | Outperform |
| 04/13/2022 | -33.35% | Barclays | $425 → $380 | Maintains | Equal-Weight |
| 04/12/2022 | -28.27% | Truist Securities | $470 → $409 | Maintains | Hold |
| 03/09/2022 | -40.02% | Wedbush | → $342 | Upgrades | Underperform → Neutral |
| 01/31/2022 | -21.08% | Citigroup | → $450 | Upgrades | Neutral → Buy |
| 01/27/2022 | -29.85% | Rosenblatt | $450 → $400 | Maintains | Neutral |
| 01/24/2022 | -27.22% | Jefferies | $737 → $415 | Downgrades | Buy → Hold |
| 01/21/2022 | 6.11% | JP Morgan | $725 → $605 | Maintains | Overweight |
| 01/21/2022 | -1.43% | Piper Sandler | $705 → $562 | Maintains | Overweight |
| 01/21/2022 | -3.54% | Pivotal Research | $750 → $550 | Maintains | Buy |
| 01/21/2022 | — | Monness, Crespi, Hardt | Downgrades | Buy → Neutral | |
| 01/21/2022 | 0.85% | UBS | $690 → $575 | Maintains | Buy |
| 01/21/2022 | 14% | BMO Capital | $700 → $650 | Maintains | Outperform |
| 01/21/2022 | -21.08% | Goldman Sachs | $580 → $450 | Maintains | Neutral |
| 01/21/2022 | 5.23% | Canaccord Genuity | $750 → $600 | Maintains | Buy |
| 01/21/2022 | -17.57% | Truist Securities | $690 → $470 | Downgrades | Buy → Hold |
| 01/21/2022 | -30.72% | Macquarie | $615 → $395 | Downgrades | Neutral → Underperform |
| 01/21/2022 | -26.34% | Baird | $575 → $420 | Downgrades | Outperform → Neutral |
| 01/21/2022 | -21.08% | Morgan Stanley | $700 → $450 | Downgrades | Overweight → Equal-Weight |
| 01/21/2022 | -7.92% | Evercore ISI Group | $710 → $525 | Downgrades | Outperform → In-Line |
| 01/21/2022 | -21.08% | Credit Suisse | → $450 | Downgrades | Outperform → Neutral |
| 01/21/2022 | -25.46% | Barclays | $675 → $425 | Downgrades | Overweight → Equal-Weight |
| 01/21/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 01/11/2022 | 8.74% | Keybanc | $725 → $620 | Maintains | Overweight |
| 01/06/2022 | 27.15% | JP Morgan | $750 → $725 | Maintains | Overweight |
| 11/15/2021 | 27.15% | Keybanc | $690 → $725 | Maintains | Overweight |
| 10/20/2021 | 31.54% | Canaccord Genuity | $650 → $750 | Maintains | Buy |
| 10/20/2021 | 23.82% | Wolfe Research | $625 → $706 | Maintains | Outperform |
| 10/20/2021 | 21.01% | Stifel | $650 → $690 | Maintains | Buy |
| 10/20/2021 | 21.01% | Keybanc | $670 → $690 | Maintains | Overweight |
| 10/20/2021 | 31.54% | Oppenheimer | $620 → $750 | Maintains | Outperform |
| 10/20/2021 | 31.54% | Cowen & Co. | $650 → $750 | Maintains | Outperform |
| 10/20/2021 | 22.77% | Morgan Stanley | $675 → $700 | Maintains | Overweight |
| 10/20/2021 | 40.31% | Wells Fargo | $700 → $800 | Maintains | Overweight |
| 10/20/2021 | 18.38% | Barclays | $625 → $675 | Maintains | Overweight |
| 10/20/2021 | 3.48% | Deutsche Bank | → $590 | Downgrades | Buy → Hold |
| 10/18/2021 | 26.28% | UBS | $620 → $720 | Maintains | Buy |
| 10/15/2021 | 23.65% | Piper Sandler | $600 → $705 | Maintains | Overweight |
| 10/15/2021 | 18.38% | Morgan Stanley | $650 → $675 | Maintains | Overweight |
| 10/12/2021 | 29.26% | Jefferies | $620 → $737 | Maintains | Buy |
| 10/12/2021 | 21.01% | Truist Securities | $600 → $690 | Maintains | Buy |
| 10/11/2021 | 29.78% | Credit Suisse | $643 → $740 | Maintains | Outperform |
| 10/11/2021 | 17.51% | Keybanc | $645 → $670 | Maintains | Overweight |
| 10/01/2021 | 20.14% | Guggenheim | $600 → $685 | Maintains | Buy |
| 09/29/2021 | -13.54% | Benchmark | $448 → $493 | Maintains | Sell |
| 09/22/2021 | 14% | Stifel | $580 → $650 | Maintains | Buy |
| 09/13/2021 | 3.48% | Goldman Sachs | → $590 | Initiates Coverage On | → Neutral |
| 09/09/2021 | 28.91% | Arete Research | → $735 | Initiates Coverage On | → Buy |
| 09/08/2021 | 23.65% | JP Morgan | $625 → $705 | Maintains | Overweight |
| 09/07/2021 | 36.8% | Atlantic Equities | $690 → $780 | Maintains | Overweight |
| 07/21/2021 | 3.48% | Deutsche Bank | $575 → $590 | Maintains | Buy |
| 07/21/2021 | 12.77% | Credit Suisse | $586 → $643 | Maintains | Outperform |
| 07/15/2021 | 8.74% | UBS | $600 → $620 | Maintains | Buy |
| 06/25/2021 | 2.77% | Credit Suisse | → $586 | Upgrades | Neutral → Outperform |
| 05/19/2021 | 8.74% | Jefferies | → $620 | Assumes | → Buy |
| 04/21/2021 | 14% | Cowen & Co. | $675 → $650 | Maintains | Outperform |
| 04/21/2021 | 14% | Canaccord Genuity | $670 → $650 | Maintains | Buy |
| 04/21/2021 | -40.02% | Wedbush | $340 → $342 | Maintains | Underperform |
| 04/21/2021 | 0.85% | Deutsche Bank | $600 → $575 | Maintains | Buy |
| 04/21/2021 | 14% | Morgan Stanley | $700 → $650 | Maintains | Overweight |
| 04/21/2021 | -7.92% | Macquarie | $600 → $525 | Maintains | Neutral |
| 04/21/2021 | 5.23% | Piper Sandler | $605 → $600 | Maintains | Overweight |
| 04/21/2021 | 26.28% | Pivotal Research | $750 → $720 | Maintains | Buy |
| 04/21/2021 | -1.79% | Stifel | $550 → $560 | Upgrades | Hold → Buy |
| 04/01/2021 | 6.11% | Piper Sandler | → $605 | Initiates Coverage On | → Overweight |
| 03/23/2021 | 14% | Argus Research | → $650 | Upgrades | Hold → Buy |
| 03/15/2021 | -17.22% | Benchmark | $485 → $472 | Maintains | Sell |
| 01/21/2021 | 14% | DZ Bank | → $650 | Upgrades | Hold → Buy |
| 01/20/2021 | 31.54% | Pivotal Research | $660 → $750 | Maintains | Buy |
| 01/20/2021 | 22.77% | Morgan Stanley | $650 → $700 | Maintains | Overweight |
| 01/20/2021 | 17.51% | Canaccord Genuity | $630 → $670 | Maintains | Buy |
| 01/20/2021 | 2.77% | Credit Suisse | $525 → $586 | Maintains | Neutral |
| 01/20/2021 | 22.77% | Wells Fargo | → $700 | Upgrades | Equal-Weight → Overweight |
| 01/20/2021 | -21.08% | Rosenblatt | $425 → $450 | Maintains | Neutral |
| 01/20/2021 | 14% | UBS | $540 → $650 | Upgrades | Neutral → Buy |
| 01/20/2021 | 14% | KeyBanc | $634 → $650 | Maintains | Overweight |
| 01/14/2021 | 1.72% | Citigroup | $450 → $580 | Maintains | Neutral |
| 01/07/2021 | 14% | Cowen & Co. | $625 → $650 | Maintains | Outperform |
| 10/21/2020 | -3.54% | Oppenheimer | $515 → $550 | Maintains | Outperform |
| 10/21/2020 | -58.78% | Wedbush | $220 → $235 | Maintains | Underperform |
| 10/21/2020 | -33.35% | Benchmark | $420 → $380 | Maintains | Sell |
| 10/21/2020 | 12.25% | Morgan Stanley | $630 → $640 | Maintains | Overweight |
| 10/21/2020 | 22.77% | BMO Capital | $625 → $700 | Maintains | Outperform |
| 10/16/2020 | 17.51% | B of A Securities | $575 → $670 | Maintains | Buy |
| 10/16/2020 | 10.49% | Morgan Stanley | $600 → $630 | Maintains | Overweight |
| 10/15/2020 | 10.49% | Canaccord Genuity | $550 → $630 | Maintains | Buy |
| 10/15/2020 | 11.19% | Keybanc | $590 → $634 | Maintains | Overweight |
| 10/07/2020 | 14% | Pivotal Research | $600 → $650 | Maintains | Buy |
| 09/28/2020 | -0.03% | Jefferies | $550 → $570 | Maintains | Buy |
| 09/28/2020 | -0.03% | Guggenheim | $530 → $570 | Maintains | Buy |
| 09/15/2020 | 3.48% | Keybanc | → $590 | Initiates Coverage On | → Overweight |
| 09/09/2020 | — | Raymond James | Reinstates | → Market Perform | |
| 09/08/2020 | -1.79% | Truist Securities | $530 → $560 | Maintains | Buy |
| 07/17/2020 | -7.05% | SunTrust Robinson Humphrey | $475 → $530 | Maintains | Buy |
| 07/17/2020 | -6.35% | Piper Sandler | $500 → $534 | Maintains | Overweight |
| 07/17/2020 | 5.23% | Morgan Stanley | $575 → $600 | Maintains | Overweight |
| 07/17/2020 | -3.54% | Jefferies | $520 → $550 | Maintains | Buy |
| 07/17/2020 | -7.92% | Deutsche Bank | $500 → $525 | Maintains | Buy |
| 07/17/2020 | -12.31% | UBS | $535 → $500 | Maintains | Neutral |
| 07/17/2020 | -29.85% | Rosenblatt | $445 → $400 | Maintains | Neutral |
| 07/17/2020 | -7.92% | Credit Suisse | $550 → $525 | Downgrades | Outperform → Neutral |
| 07/15/2020 | 0.85% | Morgan Stanley | $485 → $575 | Maintains | Overweight |
| 07/14/2020 | -61.42% | Wedbush | $198 → $220 | Maintains | Underperform |
| 07/14/2020 | -6.17% | UBS | → $535 | Downgrades | Buy → Neutral |
| 07/13/2020 | -30.37% | Benchmark | $340 → $397 | Maintains | Sell |
| 07/13/2020 | 9.61% | BMO Capital | $500 → $625 | Maintains | Outperform |
| 07/10/2020 | 17.51% | Goldman Sachs | $540 → $670 | Maintains | Buy |
| 07/08/2020 | -21.95% | Rosenblatt | $370 → $445 | Reiterates | → Neutral |
| 07/07/2020 | -3.54% | Credit Suisse | $465 → $550 | Maintains | Outperform |
| 07/06/2020 | -14.24% | Imperial Capital | → $489 | Downgrades | Outperform → In-Line |
| 06/18/2020 | -14.24% | Imperial Capital | $485 → $489 | Maintains | Outperform |
| 05/21/2020 | -21.08% | Citigroup | $350 → $450 | Maintains | Neutral |
| 05/14/2020 | -8.8% | Jefferies | → $520 | Initiates Coverage On | → Buy |
| 04/23/2020 | -16.69% | SunTrust Robinson Humphrey | $402 → $475 | Maintains | Buy |
| 04/23/2020 | -14.94% | Morgan Stanley | $450 → $485 | Maintains | Overweight |
| 04/23/2020 | -14.94% | Imperial Capital | $447 → $485 | Maintains | Outperform |
| 04/22/2020 | -16.69% | SunTrust Robinson Humphrey | $402 → $475 | Maintains | Buy |
| 04/22/2020 | -12.31% | Canaccord Genuity | $450 → $500 | Maintains | Buy |
| 04/22/2020 | -31.6% | Nomura | $330 → $390 | Maintains | Neutral |
| 04/22/2020 | -6.17% | JP Morgan | $480 → $535 | Reiterates | → Overweight |
| 04/22/2020 | -6.17% | UBS | $400 → $535 | Maintains | Buy |
| 04/22/2020 | -65.27% | Wedbush | $194 → $198 | Maintains | Underperform |
| 04/22/2020 | -40.37% | Benchmark | $327 → $340 | Maintains | Overweight |
| 04/22/2020 | -18.45% | Credit Suisse | $440 → $465 | Maintains | Outperform |
| 04/22/2020 | -12.31% | RBC Capital | $420 → $500 | Reiterates | → Outperform |
| 04/22/2020 | -15.82% | Raymond James | $415 → $480 | Downgrades | Strong Buy → Outperform |
| 04/22/2020 | -19.32% | Stifel | → $460 | Downgrades | Buy → Hold |
| 04/22/2020 | -19.32% | Wells Fargo | → $460 | Upgrades | Underweight → Equal-Weight |
| 04/17/2020 | -42.65% | Benchmark | → $327 | Initiates Coverage On | → Sell |
| 04/17/2020 | -35.11% | Rosenblatt | $275 → $370 | Reiterates | → Neutral |
| 04/16/2020 | -21.08% | Morgan Stanley | $400 → $450 | Maintains | Overweight |
| 04/16/2020 | -65.98% | Wedbush | $173 → $194 | Maintains | Underperform |
| 04/16/2020 | -14.06% | Goldman Sachs | $430 → $490 | Reiterates | → Buy |
| 04/15/2020 | -14.06% | Pivotal Research | $425 → $490 | Maintains | Buy |
| 04/15/2020 | -22.83% | Stifel | $390 → $440 | Maintains | Buy |
| 04/15/2020 | -21.95% | Cowen & Co. | $425 → $445 | Reiterates | → Outperform |
| 04/14/2020 | -19.32% | B of A Securities | $426 → $460 | Maintains | Buy |
| 04/14/2020 | -21.6% | Imperial Capital | $438 → $447 | Maintains | Outperform |
| 04/01/2020 | -46.51% | Wells Fargo | $265 → $305 | Maintains | Underweight |
| 04/01/2020 | -14.59% | Bernstein | $423 → $487 | Maintains | Outperform |
| 03/23/2020 | -27.22% | Baird | $350 → $415 | Upgrades | Neutral → Outperform |
| 03/04/2020 | -23.18% | Imperial Capital | $446 → $438 | Maintains | Outperform |
| 01/27/2020 | -38.62% | Citigroup | $325 → $350 | Maintains | Neutral |
| 01/23/2020 | -26.34% | Guggenheim | $400 → $420 | Maintains | Buy |
| 01/22/2020 | -29.85% | Oppenheimer | $385 → $400 | Maintains | Outperform |
| 01/22/2020 | -38.62% | Baird | $300 → $350 | Maintains | Neutral |
| 01/22/2020 | -51.77% | Rosenblatt | $265 → $275 | Maintains | Neutral |
| 01/22/2020 | -29.85% | UBS | $405 → $400 | Maintains | Buy |
| 01/22/2020 | -69.66% | Wedbush | $188 → $173 | Maintains | Underperform |
| 01/17/2020 | -28.97% | UBS | $370 → $405 | Maintains | Buy |
| 12/19/2019 | -25.46% | Pivotal Research | $400 → $425 | Maintains | Buy |
| 12/10/2019 | — | Needham | Downgrades | Hold → Underperform | |
| 12/03/2019 | -43% | Citigroup | $410 → $325 | Downgrades | Buy → Neutral |
| 11/25/2019 | -53.52% | Wells Fargo | $308 → $265 | Downgrades | Market Perform → Underperform |
| 10/28/2019 | -21.78% | Imperial Capital | $451 → $446 | Maintains | Outperform |
| 10/17/2019 | -26.34% | RBC Capital | $450 → $420 | Maintains | Outperform |
| 10/17/2019 | — | Huber Research | Downgrades | Overweight → Underweight | |
| 10/17/2019 | -47.39% | Baird | $370 → $300 | Maintains | Neutral |
| 10/17/2019 | -25.29% | B of A Securities | $450 → $426 | Maintains | Buy |
| 10/17/2019 | -27.22% | Cowen & Co. | $435 → $415 | Maintains | Outperform |
| 10/17/2019 | -29.85% | Piper Sandler | $440 → $400 | Maintains | Overweight |
| 10/17/2019 | -25.99% | Bernstein | $450 → $422 | Maintains | Outperform |
| 10/17/2019 | -45.98% | Wells Fargo | $288 → $308 | Maintains | Market Perform |
| 10/17/2019 | -29.85% | Guggenheim | $420 → $400 | Maintains | Buy |
| 10/17/2019 | -42.12% | Nomura | $310 → $330 | Maintains | Neutral |
| 10/17/2019 | — | Macquarie | Downgrades | Outperform → Neutral | |
| 10/14/2019 | -27.22% | Raymond James | $450 → $415 | Maintains | Strong Buy |
| 10/14/2019 | -29.85% | Morgan Stanley | $450 → $400 | Maintains | Overweight |
| 10/10/2019 | -35.11% | UBS | $420 → $370 | Maintains | Buy |
| 10/10/2019 | -36.86% | Goldman Sachs | $420 → $360 | Maintains | Buy |
| 10/09/2019 | -53.52% | Rosenblatt | $330 → $265 | Maintains | Neutral |
| 10/09/2019 | -40.37% | Monness, Crespi, Hardt | $440 → $340 | Maintains | Buy |
| 10/07/2019 | -47.39% | Evercore ISI Group | $380 → $300 | Maintains | In-Line |
| 09/24/2019 | -38.62% | Pivotal Research | $515 → $350 | Maintains | Buy |
| 09/24/2019 | -49.49% | Wells Fargo | → $288 | Initiates Coverage On | → Market Perform |
| 08/29/2019 | -20.9% | Imperial Capital | $458 → $451 | Maintains | Outperform |
| 07/18/2019 | -28.09% | Citigroup | $420 → $410 | Maintains | Buy |
| 07/18/2019 | -22.83% | Credit Suisse | $450 → $440 | Reiterates | → Outperform |
| 07/18/2019 | -22.83% | BMO Capital | $470 → $440 | Maintains | Outperform |
| 07/18/2019 | -67.03% | Wedbush | $183 → $188 | Maintains | Underperform |
| 07/18/2019 | -45.63% | Nomura | $320 → $310 | Maintains | Neutral |
| 07/18/2019 | -21.08% | Raymond James | $470 → $450 | Maintains | Strong Buy |
| 06/04/2019 | -25.46% | Loop Capital | $395 → $425 | Upgrades | Hold → Buy |
| 04/26/2019 | -19.67% | Imperial Capital | $463 → $458 | Maintains | Outperform |
| 04/17/2019 | -21.08% | Credit Suisse | $440 → $450 | Maintains | Outperform |
| 04/17/2019 | -67.9% | Wedbush | $165 → $183 | Maintains | Underperform |
| 04/17/2019 | -28.09% | Oppenheimer | $425 → $410 | Maintains | Outperform |
| 04/17/2019 | -37.21% | Buckingham Research | $382 → $358 | Maintains | Neutral |
| 04/16/2019 | -17.57% | BMO Capital | $440 → $470 | Maintains | Outperform |
| 04/16/2019 | — | Deutsche Bank | Upgrades | Hold → Buy | |
| 04/02/2019 | -38.62% | Rosenblatt | → $350 | Initiates Coverage On | → Neutral |
| 03/08/2019 | -33% | Buckingham Research | → $382 | Downgrades | Buy → Neutral |